Home › Steatotic Liver Disease › Missouri › Columbia
Steatotic Liver Disease clinical trials in Columbia, MO
5 studies for Steatotic Liver Disease are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Columbia
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Gastrointestinal Associates, Columbia
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
RecruitingObservational studyHealthy volunteers welcome
- University of Missouri School of Medicine, Columbia
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
RecruitingHealthy volunteers welcome
- University of Missouri School of Medicine, Columbia
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
RecruitingPhase 2
- Harry S. Truman Memorial, Columbia, MO, Columbia
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
- St. Louis, MO9 studies
Other studies in Columbia
- Obesity12 studies
- Non-Small Cell Lung Cancer8 studies
- Colorectal Cancer7 studies
- Myasthenia Gravis6 studies
- Cancer (all types)6 studies
- Type 2 Diabetes6 studies
- Breast Cancer6 studies
- Heart Failure5 studies
- Cardiovascular Disease5 studies
- Lung Cancer5 studies
- Cerebral Hemorrhage4 studies
- High Blood Pressure4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.